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Quantitative real-time PCRBackground: Quantitative real-time PCR (qPCR) is the ‘‘gold-standard’’ technique for measuring mRNA
abundances. To correctly compare samples and generate biologically valid results, qPCR data usually
require comprehensive normalization to account for sample content variation between reactions. The
most common normalization approaches use one or more endogenous controls (reference or house-keep-
ing genes) to adjust the measured levels of experimental genes appropriately. Ideal reference genes are
those that display minimal variation across experimental conditions, and thus can vary widely across dif-
ferent biological systems. In particular, toxicogenomic studies of transcriptionally-disruptive toxins, like
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), require careful consideration of reference genes.
Results: We examined seven candidate reference genes in 199 mice varying in genotype and time/dose of
TCDD exposure. We assessed gene-stability in four ways: (1) the variance of the raw Cq values across bio-
logical replicates, (2) the fold-change from basal mRNA levels following treatment, (3) the inter- and
intra-group stability evaluated using the NormFinder algorithm, (4) the comparative DCq method for
each candidate gene.
Results: Univariate analyses showed Hprt and Eef1a1 are the two most stable individual reference
genes. It has been suggested that using multiple genes would produce a more consistent normalization
factor; multivariate analysis was performed using NormFinder. In general, stability increased with the
number of genes used, but speciﬁc gene-combinations synergized.
Conclusions: We have validated seven reference genes for use in analyzing mRNA abundances in mouse
models of TCDD toxicity. The use of multiple reference genes increases stability, providing more consis-
tent normalization and more reliable results. The number of reference genes used should be maximized,
based on experimental capabilities (platform, sample availability, etc.). Our results show the beneﬁt of
validating reference genes using multiple methods prior to generating large biological datasets.
 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY-NC-ND license. 1. Introduction
The measurement of cellular materials, such as mRNA, has
increasingly become an important tool in toxicological studies
[3,17,40]. Quantitative real-time PCR (qPCR) is a fast, highly accu-
rate, sensitive, experimentally efﬁcient, and reproducible method
of quantifying mRNA abundance [15], and has thus become the
gold-standard for mRNA abundance studies. However, accurate
assessment of RNA abundance, including non-coding and mRNA,
requires thorough normalization of qPCR-generated data. This nor-
malization is intended to adjust for varying amounts of starting
material between reactions and different enzymatic efﬁciencies.
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allows multiple reactions to be compared. An effective reference
gene will maintain a consistent level of mRNA abundance across
various tissue-types, regardless of environmental conditions.
Therefore, these genes often perform a function essential for cell
survival, and are sometimes called ‘‘housekeeping genes’’. Refer-
ence genes such as glyeraldehyde-3-phosphate dehydrogenase
(Gapdh) and beta-actin (Actb) have been frequently used for qPCR
data normalization [43]. However, recent studies have shown that
these reference genes do not maintain stable mRNA abundance
levels under many experimental conditions [11,14,39]. Rather, dif-
ferences in tissues [44], experimental manipulation [36], experi-
ment duration [48], organism (between and within species) [36]
and reagents used [19] can affect the mRNA abundance levels of
candidate reference genes. It is therefore essential that candidate
reference genes be evaluated ﬁrst under experimental conditions
similar to those in the biological study.
Dioxins embody a class of environmental contaminants primar-
ily produced through industrial processes such as electronics recy-
cling [41], power generation, and the manufacture of herbicides
and pesticides [23,37]. The most potent dioxin congener is
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which induces highly
variable toxic responses among rodent species. This makes it of
particular interest to the ﬁeld of toxicology. TCDD is lipid-soluble
and bioaccumulates within fat stores; at current background expo-
sure levels, it has a half-life in adult humans of approximately 7–
12 years [2,25]. In animal models, exposure to even a single dose
of dioxins can lead to a wasting syndrome followed by death
[38]. In humans, high short-term exposure often results in liver
damage and chloracne, while long-term exposure to lower levels
has been linked to diabetes [20], immune deﬁciency [46], and a
variety of cancers [4,23].
TCDD exerts its effects by acting as a ligand for the Aryl Hydro-
carbon Receptor (AHR) [28]. Binding of TCDD to cytoplasmic AHR
leads to formation of a ligand-receptor complex which then trans-
locates into the nucleus and dimerizes with the Aryl Hydrocarbon
Receptor Nuclear Translocator (ARNT). The ligand-AHR/ARNT com-
plex has been shown to alter the transcriptional regulation of
numerous genes [27]. Previous studies have indicated the dysreg-
ulation upwards of 3000 genes in sensitive animals following TCDD
exposure [7]. Although the mechanism by which the AHR pathway
alters transcription is well characterized, speciﬁc transcriptional
changes which result in the biological manifestations of TCDD-
mediated toxicities remain unclear. Extensive mRNA abundance
studies are required in order to clarify the speciﬁc target genes
responsible for the severe toxicity of TCDD.
Mouse and rat models have been used extensively to elucidate
the mechanism by which AHR activation by TCDD leads to toxicity.
In particular, many groups have exploiting the varying TCDD-sen-
sitivities of different species and strains of rodents. For example,
the Long-Evans rat strain (Turku/AB; L-E) displays a very low toler-
ance for TCDD (LD50 10 lg/kg of TCDD) while the Han/Wistar rat
(Kuopio; H/W) is essentially refractory to TCDD-induced lethality
(LD50 > 9600 lg/kg) [32]. This difference in sensitivity is caused
by a point mutation in the H/W Ahr that creates a cryptic splice-
site, resulting in two isoforms of the AHR protein [33]. Although
these variant proteins maintain functionality, a subset of target
genes is differentially-expressed according to the speciﬁc AHR iso-
forms present (variant vs. wild-type) [13]. Thus it is hypothesized
that these genes may be responsible for the manifestation of
strain-speciﬁc TCDD toxicities. Similarly, different strains of mice
vary in their TCDD sensitivity. Both C57BL/6 and DBA/2 mice exhi-
bit toxic effects following TCDD exposure, but DBA/2 require a dose
approximately 10 to 20 times greater than that required by C57BL/
6 to induce toxic effects [10]. A point mutation in the ligand bind-
ing domain of the DBA/2 Ahr is the likely cause for this difference[34]. Sex also plays a role in TCDD–AHR activity, with female rats
being more sensitive to TCDD-lethality than males. In mice this
relationship is inverted, with females being more resistant than
males [30].
It is evident that further studies investigating the TCDD-in-
duced transcriptional changes are necessary to fully understand
the various observed toxicities. However, in order for these studies
to proceed, there is a pressing need for validated reference genes
within these model systems. We previously identiﬁed and vali-
dated several reference genes for use in rat models of TCDD toxic-
ity [31]. However, there are no validated reference genes for use in
mouse models, despite widespread use. Since rats and mice differ
dramatically in their transcriptomic responses to TCDD [6,8], it is
unclear if these rat reference genes will be useful in studies using
mice. Therefore, we examined here those genes previously identi-
ﬁed as suitable reference genes for rat-TCDD studies to determine
their validity in similar mouse model systems. Seven candidates
(Gapdh, Hprt, Pgk1, Rpl13a, Sdha, Ppia, and Eef1a1) have been as-
sessed using four separate methods for constant mRNA abundance
levels in murine hepatic tissue from various mouse models treated
with varying TCDD doses and collected at multiple times following
exposure.2. Methods
2.1. Animal handling
C57BL/6 mice were bred in the colonies of the National Public
Health Institute, Division of Environmental Health, Kuopio, Fin-
land. This study included female C57BL/6 wild-type mice, male
C57BL/6 wild-type or transgenic mice and male DBA/2J mice. Ani-
mals were generally used at 12–15 weeks old, however the age of
the transgenic mice ranged up to 23 weeks. Animals were housed
with environmental conditions maintained at 21 ± 1 C with a rel-
ative humidity of 50 ± 10% and a 12 h light cycle (12 h of light fol-
lowed by 12 h of dark) in suspended, wire-mesh stainless-steel
cages or in Makrolon cages with aspen chip bedding (Tapvei Oy,
Kaavi, Finland). Animals were housed singly to avoid aggressive so-
cial behavior. Mice were provided with Altromin 1314 pellet feed
(Altromin Spezialfutter GmbH & Co. KG, Lage, Germany) and water
available ad libitum. The study plans were approved by the Finnish
National Animal Experiment Board (Eläinkoelautakunta, ELLA; per-
mit code: ESLH-2008-07223/Ym-23).2.2. Experimental design
Ten different experiments, comprising 199 total mice were used
(Table 1). TCDD was dissolved in corn oil and administered by oral
gavage (10 mL/kg). Mice treated with corn oil alone acted as con-
trols in each experiment.
Experiments 1–5 (Fig. 1A) were time-course studies in which a
single dose of TCDD was given at time zero, and mice were eutha-
nized at different time points afterwards. Experiment E1 (n = 18)
included both male and female C57BL/6 mice treated with either
0 or 500 lg/kg of TCDD and euthanized 6 h post-treatment. E2
(n = 24) consisted of male DBA/2J and transgenic C57BL/6 mice
which harbored the rat wild-type allele of the Ahr [29]. These were
treated with 0, 5 or 500 lg/kg TCDD and were euthanized after
19 h. E3 (n = 17), E4 (n = 18), and E5 (n = 17) all included both male
and female C57BL/6 mice that received either 0 or 500 lg/kg TCDD.
The mice from these experiments were sacriﬁced at 24, 72, and
144 h, respectively.
Experiments 6–10 (Fig. 1B) were dose–response studies utiliz-
ing mice treated with a single dose of 125, 250, 500, or 1000 lg/
kg TCDD and then euthanized 96 h following treatment. E6
Table 1
Experimental design.
Study Strain Sex Genotype Treatment (TCDD lg/kg) Time of tissue harvest (hours) Number of animals
Experiment 1 C57BL/6 Male, female WT 0, 500 6 18
Experiment 2 C57BL/6
DBA/2J
Male rWT
Ala375Val
0, 5, 500 19 24
Experiment 3 C57BL/6 Male, female WT 0, 500 24 17
Experiment 4 C57BL/6 DBA/2 J Male, female WT 0, 500 72 18
Experiment 5 C57BL/6 Male, female WT 0, 500 144 17
Experiment 6 C57BL/6 Male WT 0, 125, 250, 500, 1000 96 20
Experiment 7 C57BL/6 Male DEL 0, 125, 250, 500, 1000 96 21
Experiment 8 C57BL/6 Male INS 0, 125, 250, 500, 1000 96 22
Experiment 9 C57BL/6 Male rWT 0, 125, 250, 500, 1000 96 18
Experiment 10 C57BL/6 Female WT 0, 125, 250, 500, 1000 96 24
Ten experiments were used in this study. Studies varied in the combination of gender, Ahr allele, treatment (dose(s) of TCDD) and time-points at which tissue was collected.
Fig. 1. Experimental design. (A) Outline of the experimental design for the time-
course study. Mice were treated with either 0, 5 or 500 lg/kg TCDD in corn oil
vehicle and euthanized at speciﬁc time-points following exposure. Male (blue) and
female (pink) C57BL/6 mice were euthanized at 6, 24, 72 or 144 h post-exposure
while male DBA/2J and ratonized-WT mice were collected at 19 h post-exposure.
(B) The experimental design for the dose–response study. Male (blue) ratonized
mice or female (pink) C57BL/6 mice were treated with a single dose of 0, 125, 250,
500 or 1000 lg/kg TCDD in corn oil vehicle and euthanized 96 h following exposure.
(For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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(n = 21), E8 (n = 22), and E9 (n = 18) used male transgenic mice. E7
consisted of transgenic mice containing the H/W deletion variant
(the resultant AHR protein lacks 43 amino acids at position 766)
[26]. E8 included mice containing the H/W insertion variant of
the Ahr gene (resulting in an AHR isoformwith an insertion of 7 no-
vel amino acids at position 808 and a lack of the remaining 45 ami-
no acids at the C-terminus) [26]. E9 consisted of mice harboring
the rat wild-type Ahr. Finally, E10 (n = 24) consisted of female
wild-type C57BL/6 mice.
All animal handling and reporting comply with ARRIVE guide-
lines [16].2.3. RNA isolation
In all cases, mouse livers were excised and snap-frozen in liquid
nitrogen following euthanasia by carbon dioxide exposure. Liver
tissue was shipped on dry ice to the analytical laboratory and
stored at 80 C or colder. Prior to RNA isolation, tissue samples
were ground to a ﬁne powder in liquid nitrogen using a mortar
and pestle followed by addition of lysis buffer and rapid homoge-
nization using a Brinkmann Polytron (Polytron PT1600E with a
PT-DA 1607 generator). An RNeasy Mini Kit (Qiagen, Mississauga,
Canada) was used to extract RNA from the homogenized samples
according to the manufacturer’s instructions. Quantiﬁcation of to-
tal RNA was performed using a NanoDrop UV spectrophotometer
(Thermo Scientiﬁc, Mississauga, ON). RNA integrity was deter-
mined by electrophoresis using RNA 6000 Nano kits on an Agilent
2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). All
RNA samples had an RNA integrity number above 8.5 and were
used in downstream analyses. cDNA was generated using High
Capacity cDNA Reverse Transcription Kits (Applied Biosystems,
Carlsbad, CA) following the manufacturer’s recommended protocol
and the product was diluted to produce a ﬁnal concentration of
5 ng/lL cDNA.
2.4. Quantitative PCR
qPCR was carried out in 384-well plates on the Applied Biosys-
tems 7900HT Fast Real-Time PCR System (Applied Biosystems)
using the manufacturer’s default settings for absolute quantiﬁca-
tion of standard Cq. Each 10 lL reaction contained 5 ng cDNA, 1
gene-speciﬁc PrimeTime assay (Supplementary Table 1; Integrated
DNA Technologies, Corralville, IA), and TaqMan Gene Expression
Master Mix (Applied Biosystems). Pre-designed PrimeTime assays
were used (Integrated DNA Technologies; January 2012). Reaction
efﬁciencies for each primer/probe set were determined to be be-
tween 82% and 102%. Every reaction was performed in at least
duplicate. Samples were assessed for the presence of genomic
DNA ampliﬁcation by including a reaction that did not contain re-
verse transcriptase, and these were run in parallel with each cDNA
sample assayed. Similarly, no-template controls were run with
each primer/probe set used. Brieﬂy, the PCR consisted of an initial
incubation step at 95 C for 10 min followed by 40 cycles of 95 C
for 15 s and 60 C for 1 min. Baseline and threshold values were
automatically detected using the Sequence Detection System Soft-
ware v2.3 (Applied Biosystems) with default settings. The above
qPCR processes and subsequent reporting all comply with MIQE
guidelines [9].
2.5. Western analysis
Protein levels for candidate genes were determined by quanti-
tative western blotting of mouse liver protein. Brieﬂy, total protein
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(Invitrogen, Burlington, ON) supplemented with cOmplete prote-
ase inhibitor cocktail (Roche, Laval, QC). Protein extract was quan-
tiﬁed by Bradford assay and diluted to a concentration of 10 lg/lL.
A total of 10 lg protein extract was loaded into each well of a No-
vex 4–12% Bis–Tris gel system and electrophoresed for 40 min at
200 V with MES running buffer (Invitrogen). Proteins were trans-
ferred to PVDF membranes using the iBlot system program P0 for
7 min (Invitrogen). Primary antibodies were purchased from Santa
Cruz and were used at a 1:500 dilution in Li-Cor blocking buffer,
with overnight incubation at 4 C. Blots were washed three times
with PBS supplemented with 0.1% tween 20 at room temperature
for 5 min. The Li-Cor IRDye-labeled secondary antibodies were
purchased from Mandel Scientiﬁc and used at a dilution of
1:10,000 in Li-Cor blocking buffer and incubated at room temper-
ature for 1 h. After washing the blots as described, they were ana-
lyzed with the Odyssey (Li-Cor Biosciences, Lincoln, NE, USA)
quantitative western blot near-infrared system using default
settings.
2.6. Statistical analyses and visualization
Collected Cq values were loaded in the R statistical environment
(v2.15.1) for all analyses. The mean Cq with standard deviation for
each candidate gene was determined for each experimental condi-
tion. These values were then used to determine the mean and stan-
dard deviation of the Cq values across all conditions, and standard
deviations were used to identify the candidate with the least vari-
ation, as suggested by ABI [18]. A similar method has been used to
evaluate several of our candidate reference genes within human
CD4+ T cells andmonocytes [21]. The log2 |fold-change| of each ref-
erence gene was calculated as the difference in Cq values between
treated and control animals. In addition, two popular algorithms,
NormFinder [1] and the comparative DCq method [42], were used
to determine the most stable reference gene. Candidate genes were
analyzed both individually and in all possible combinations. All
possible combinations of the seven candidate genes were arranged
using the gregmisc (v2.1.2) package for R and all visualizations
were produced using the lattice (v0.20-10) and latticeExtra (v0.6-
24) R packages.
The mRNA abundances were assessed across both the time-
course and the dose–response experiments. Each treatment group
(biological replicate) was compared to a control group of the same
gender, strain, genotype and time-point, which was not
exposed to TCDD. Unpaired, two-tailed Student’s t-tests were used
to evaluate differential mRNA abundance levels between control
and treatment groups using the Cq values for each individual can-
didate reference gene. The magnitude (M) of the differences was
evaluated using the log2|fold-change| and deﬁned as follows:
½M ¼ log2ð2DCq Þ; where DCq ¼ CqðTCDDÞ  CqðCornoilÞ. Both individual
genes and each combination of genes were assessed. Results were
visualized as M ± standard-deviation across all experimental
conditions.
The NormFinder algorithm [1] estimates the overall variation of
mRNA abundance levels for a candidate reference gene by analyz-
ing its variance both within an experimental group and across
experimental conditions. The geometric mean of the Cq values for
technical replicates was calculated and transformed as follows:
½Cq ¼ 2geometric mean ðCqÞ. Samples were identiﬁed as belonging to
either control or treatment groups and were evaluated using the
NormFinder algorithm in the R statistical environment (v2.15.1).
Interpretation of NormFinder output is as follows: a lower value
indicates more consistent mRNA abundance levels across experi-
mental groups signifying a potentially good reference gene. Proﬁles
utilizing multiple candidate genes were evaluated using the geo-
metric mean of the Cq values for the pertinent genes.The comparative DCq method was used to compare Cq values
between each pair of candidate genes within each sample. The can-
didate with the least variation (the smallest mean standard devia-
tion across comparisons) was considered to be the most stably
expressed [42].3. Results
Experiments were divided into two categories: time-course
(Fig. 1A) and dose–response (Fig. 1B) studies. qPCR ﬁndings were
validated by considering mRNA abundance levels determined by
microarray data from a subset of these animals; similar results
were obtained (data not shown).3.1. Univariate comparison of genes
We ﬁrst evaluated the variation of raw Cq values for each candi-
date gene across all experimental conditions (Table 2, Supplemen-
tary Fig. 1). Hprt had the smallest standard deviation across all
experiments while Sdha had the largest (average r = 0.50 and
1.40, respectively). As this increased variation may result from
TCDD-mediated alteration of mRNA levels, we next assessed the
differential expression between treated and untreated animals.
The extent of TCDD-treatment on the mRNA levels of the candi-
date genes can be assessed from the fold-difference between basal
and TCDD-altered mRNA levels. This was calculated for each gene
at each treatment condition (Supplementary Table 2). The fold-
changes for two representative candidate genes, Eef1a1 and Gapdh,
are shown for all time-course (Fig. 2A) and dose–response (Fig. 2B)
experiments. Similar plots for the fold-change in mRNA levels of
the ﬁve remaining candidate genes are shown in Supplementary
Fig. 2. Given that an ideal reference gene will maintain a consistent
level of mRNA abundance, regardless of experimental conditions,
the more suitable reference gene will be one with minimal fold-
change variation within and between experimental conditions. Un-
paired Student’s t-tests were performed to assess the statistical
signiﬁcance of the fold-changes for each gene at each experimental
condition (Supplementary Table 2). This analysis indicated that
Eef1a1 displayed the least variation between treated and untreated
animals (9/33 experimental conditions with p < 0.05). In contrast,
26/33 experimentally unique groups had signiﬁcantly differential
expression of Rpl13a between treated and untreated animals (Ta-
ble 2). Pearson’s correlations were then used to assess the similar-
ity of variation across experimental conditions between all genes
(Fig. 3). Hprt, Ppia, and Rpl13a are well correlated, as are Gapdh
and Sdha, indicating similar direction of inﬂuence by TCDD-
treatment.
The above approaches were applied independently to each
combination of candidate gene and experimental condition. The
distributions of these assessments were then compared across
genes to determine overall trends. To address this comparison of
conditions in a more global and quantitative fashion, we evaluated
the gene stability using the NormFinder algorithm [1]. Unlike the
prior methods, this approach requires a relatively large number
of samples and recommends the assessment of 5–10 candidate
genes simultaneously in order to produce valid results. NormFind-
er ranks each gene based on its intra- and inter-group variation in
mRNA abundance levels, as well as the systematic differences be-
tween groups. This value represents the amount of variation: can-
didates with a higher value display greater variation (instability)
across experiments; however, it is important to note that the mag-
nitude of these values is less signiﬁcant than the ranking of the
candidate genes. In order to validate the reproducibility of the can-
didate rankings, experiments were randomly divided into two
datasets: the training set included experiments 1, 4, 6, 8, and 9
Table 2
Summary of analysis methods.
Cq variation (ABI) Unpaired Student’s t-test NormFinder Comparative DCq
Training Validation
Variation within
groups biological
replicates
Comparison between
groups biological
replicates
96 Animals inter-group
and intra-group
variance
103 Animals inter-group
and intra-group
variance
Comparison between
genes technical replicates
Eef1a1 3.32 0.88 9/32 0.098 0.181 1.35
Gapdh 4.83 1.25 18/32 0.121 0.128 1.50
Hprt 2.00 0.50 17/32 0.089 0.137 1.29
Pgk1 5.28 0.99 11/32 0.120 0.171 1.35
Ppia 3.23 0.84 19/32 0.115 0.154 1.54
Rpl13a 4.93 1.18 26/32 0.148 0.166 1.55
Sdha 6.57 1.40 16/32 0.183 0.203 1.76
Four separate analyses were used to assess the stability of each individual candidate gene: (1) Cq variation (range, StDEV) was calculated across all experimental groups. (2)
Student’s t-tests were performed between treated and untreated animals for each experimental condition; groups with a signiﬁcant p-value (<0.05) were determined to be
altered by TCDD. (3) NormFinder assessed the consistency of each candidate using both the inter- and intra-group variation. (4) The comparative DCq method assessed the
affect of normalization of all genes using each candidate; the average standard deviation for each pair-wise comparison is reported.
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5, 7, and 10) (n = 96 and 103, respectively). NormFinder was then
run independently upon each dataset and results were compared
between them (Fig. 4, Supplementary Table 3). The two sets of
experiments generated only partially-similar results: Hprt and
Eef1a1 were the most stable genes in the training dataset, while
Hprt and Gapdh were identiﬁed in the validation dataset. Sdha
was indicated as the least stable candidate in both datasets
(Table 2).
To this point all candidate genes were assessed individually
across varying experimental conditions. Alternatively, the variabil-
ity of a candidate gene can be assessed through its capacity to gen-
erate consistent normalized expression levels of other candidate
genes. The normalized expression level (NEL) of a given mRNA is
typically calculated using the difference in Cq from the reference.
Any variation between two candidate genes across experimental
conditions indicates variation in one or both of those genes, and
can be used to determine overall stability [44]. To this end, we per-
formed analysis of each candidate gene using the comparative DCq
method [42] (adapted from geNorm [44]) to determine the overall
variance when compared to all other candidate genes, producing
similar results as the above methods. The difference between Cq
values (DCq) for each pair of candidate genes was calculated for
each individual sample. The mean and standard deviation for these
values was calculated across all samples. Finally, the mean of the
standard deviations was used to determine the variation for each
candidate gene. By this method, Hprt, Eef1a1, and Pgk1 were the
least variable across experimental conditions (Table 2, Supplemen-
tary Table 4).Fig. 2. Time-course and dose–response of Eef1a1 and Gapdh. Fold changes were
calculated and compared across all conditions present in the (A) time-course and
(B) dose–response studies. Candidate reference genes Eef1a1 and Gapdh are shown.
Points represent the fold change (in log2 space) of the TCDD-treated animals
compared with the control animals of the same biological conditions. Error bars
indicate the standard deviation within each group. Different point types (B) indicate
separate dose–response studies.3.2. Multivariate analysis
Lastly, we sought to consider how these genes could work to-
gether as a reference set, which may be more effective because
not all genes in a set are likely to be altered by the same experi-
mental condition [44]. To test this, the stability of all possible com-
binations of the candidate genes in this study was assessed using
the NormFinder algorithm. NormFinder was used to rank all possi-
ble combinations of the seven candidate genes using the geometric
mean of their Cq values for each treatment group. As above,
experiments were divided into training and validation sets and
NormFinder was run independently on each (Fig. 5). Ideal combi-
nations of reference genes will have smaller instability values (thus
having increased stability) and be reproducible in the validation
set.
Generally, it was found that stability increased with a larger
number of genes input into NormFinder (Spearman’s rho: 0.68,
p < 0.01) (Fig. 5A). In fact, the greatest stability was achieved byusing all seven candidate genes. Although using more genes gener-
ally improved stability, certain combinations of genes performed
Fig. 3. Correlation of candidate genes. Fold changes were calculated for each
experimental condition and Pearson’s correlations used to compare each pair of
candidate genes. Correlations were visualized using a heatmap and organized using
divisive clustering. Blue indicates perfect correlation; green represents inverse
correlations while black indicates little or no correlation. R values are shown in
white for each pair-wise comparison. (For interpretation of the references to color
in this ﬁgure legend, the reader is referred to the web version of this article.)
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outperformed all combinations of 2–5 genes and many combina-
tions of genes performed differently in the training and validation
sets (Fig. 5B). Similarly, certain groups of candidates ranked differ-
ently between the two datasets (Fig. 5C), with the inclusion of cer-Fig. 4. Univariate analysis of gene stability by NormFinder. Experiments were
separated into training and validation sets, ensuring similar treatment conditions
appeared in both sets. Each gene was analyzed using the NormFinder algorithm (see
Section 2.6) to determine stability across all treatment groups. A lower value
indicates less variance across all experimental conditions.tain candidates contributing more than others to increased
stability (Supplementary Fig. 3).
To verify the multivariate results, two of the top combinations
of genes, as determined by NormFinder for both the training and
validation sets, were visualized across all experimental conditions
for both time-course and dose–response studies (Fig. 6A and B,
respectively). The most stable combination included all seven can-
didate genes, followed closely by this combination without Hprt.
This is despite our ﬁndings that Hprt is the most stable individual
gene in our study, indicating that the number of genes used for
normalization of qPCR data is more relevant than the identity of
those genes.4. Discussion
Quantitative real-time PCR is the ‘‘gold-standard’’ for determin-
ing mRNA abundance due to its high accuracy and sensitivity.
However, accurate interpretation of results requires data normali-
zation typically using stable endogenous controls. Suitable refer-
ence genes are those proven to maintain stable transcript levels
across all experimental treatments and conditions. Failure to select
and validate appropriate reference genes may cause inaccurate
interpretation of results. In fact, it is seldom appreciated that most
studies (including ours) do not describe reference genes per se, but
rather speciﬁc target regions of that gene that are stable under
speciﬁed conditions: different splice-variants or isoforms may re-
spond differently to experimental conditions [12]. Similarly, valid-
ity of reference genes may not be consistent between RNA and
protein analyses: these two species are only weakly correlated
[22]. For example, in the samples used in this study, matched
mRNA and protein levels for Eef1a1 are uncorrelated across exper-
imental conditions (q = 0.16, p > 0.01; Supplementary Fig. 4, Sup-
plementary Table 5). Therefore, it is extremely important for
candidate reference genes to ﬁrst be validated across all experi-
mental conditions. The applicability of results discussed here are
dependent on the speciﬁc gene regions and qPCR assays reported
in Supplementary Table 1, although of course may be extensible
to other untested regions.
The toxic effects of TCDD have been shown to be mediated
through its interaction with the AHR which results in alteration
of mRNA abundance levels for numerous genes [27]. The exact
transcriptional changes responsible for the resultant toxic effects
of TCDD are still unknown; therefore, further study is required.
Due to this large effect of TCDD on transcription, it is imperative
that potential reference genes are ﬁrst evaluated in the relevant
animal models. Reference genes for rat models of TCDD toxicity
have been previously identiﬁed [31], however, there has yet to
be a study validating candidate reference genes in mouse models
treated with TCDD. Similarly, as there is a large degree of inter-
strain heterogeneity within rat models exposed to TCDD [5,47],
mRNA abundance proﬁles may vary between different mouse
models. While phenotypic and sequence homology suggest a gen-
eral tendency for reference genes to remain suitable across strains
or species, this is not guaranteed and, in fact, our study has clearly
demonstrated this.
This study was designed to determine whether reference genes
previously validated in rat models treated with TCDD would be
suitable for the normalization of RNA abundance data in mouse
models of TCDD toxicity. Abundance of mRNA for the seven candi-
date reference genes was determined for numerous mouse models,
including mice of different genders, strains and Ahr-genotypes,
which were treated with varying doses of TCDD for various time
points. mRNA abundance data were generated using qPCR and ana-
lyzed to identify differences across experimental conditions in all
mouse models used. Four methods were employed: (1) the
S.D. Prokopec et al. / Chemico-Biological Interactions 205 (2013) 63–71 69variation of the raw Cq values [18], (2) the abundance fold-change
between treated and untreated animals, (3) the NormFinder algo-
rithm for gene stability [1] and (4) the differential abundance be-
tween each pair of candidate genes (comparative DCq) [42,44].
While each method used different approaches, they generated sim-
ilar rankings of candidate genes (summarized in Table 2).
Since some variation is expected for any given gene across bio-
logically identical samples, it may be more appropriate to compare
levels of mRNA abundance between treated and untreated animals.
Ideally, suitable reference genes will display minimal TCDD-medi-
ated abundance differences. We performed unpaired Student’s t-
tests and evaluated the fold-difference between treated and un-
treated animals of identical origins (strain, gender, Ahr-genotype)
and determined that Eef1a1 showed the least variation across all
treatment regimens (Fig. 2) while Rpl13a displayed the most
variance.
An alternative to the analysis of the fold-difference between ba-
sal and treated mRNA levels, the comparative DCq method exam-
ined the fold-difference between each pair of candidate genes in
order to determine the extent of treatment-induced alteration be-
tween genes. If experimental conditions induced alterations in oneFig. 5. Multivariate analysis of gene stability by NormFinder. Experiments were separated
both sets. Each gene, and all possible combinations of genes, was analyzed using the Norm
A lower value indicates less variance across all experimental conditions. (A) Combinat
determine the optimal number of genes. (B) Results for each combination of candidates
Points represent the stability values generated for each combination and are grouped acco
plotted for both the training and validation experiments. Combinations are organized acco
experimental conditions.gene while leaving another unaffected, the variation would be
greater than if both genes were similarly altered. This method
established that Hprt displayed minimal variation, indicating that
it is the most stable candidate while Sdha was again the least.
The NormFinder algorithm considers variation within and
across experimental groups to determine the overall stability of a
candidate gene. NormFinder analysis indicated that Hprt was in-
deed among the most stable of our candidates (displaying greater
stability compared to other candidates in both the training exper-
iments and the validation set) and that Sdha was the least stable,
regardless of experimental conditions (Fig. 4).
The use of multiple endogenous genes has been shown to gen-
erate more accurate results, with general opinion that using the
geometric mean of a minimum of three stable, non-co-regulated
genes would be most suitable [42,44]. Therefore, we evaluated
all possible permutations of our candidate genes using the Norm-
Finder algorithm. This analysis conﬁrmed that, in general, combin-
ing multiple genes produces a more stable value for normalization.
In fact, the use of a larger number of genes is far more critical than
the selection of any speciﬁc individual gene, likely up to a maximal
number not determined here. For example, the most stableinto training and validation sets, ensuring similar treatment conditions appeared in
Finder algorithm (see Section 2.6) to determine stability across all treatment groups.
ions were organized according to the number of included candidates in order to
were compared between the training and validation sets to visualize concordance.
rding to the number of genes used. (C) Results for each combination of gene(s) were
rding to performance in the training set: a lower value indicates less variance across
Fig. 6. Multivariate analysis of time-course and dose–response experiments. Fold changes were calculated using the geometric mean of multiple genes and compared across
all conditions present in the (A) time-course and (B) dose–response studies. Points represent the fold change (in log2 space) across a single biological condition with error bars
to indicate the standard deviation within the group. The geometric mean of either all seven genes assessed (top) or the best group of six genes (bottom) are shown.
70 S.D. Prokopec et al. / Chemico-Biological Interactions 205 (2013) 63–71combination of six genes actually excludes the single most univari-
ately stable gene (Hprt). Additionally, the use of seven genes is
more stable than any combination of six genes, further highlight-
ing this phenomenon (Fig. 5B). This suggests that the number of
reference genes implemented is the most signiﬁcant factor; the
inclusion of more genes is better and outweighs the speciﬁc genes
used. However, if using a combination of six or seven reference
genes is not experimentally feasible, it is possible to implement a
carefully selected combination of fewer genes while still upholding
stability: the most stable pair of genes, Gapdh and Ppia, demon-
strated less variation than several groups consisting of a greater
number of genes.5. Conclusions
Although several new methods of interrogating mRNA abun-
dances are being generated, these still generally require the use
of control genes for data analysis [35,45]. The results of this study
indicate that not all genes which remain stable in rats treated with
TCDD are optimal reference genes in a murine model. In particular,
while both Rpl13a and Sdhawere shown to be unchanged following
TCDD-exposure in rat liver [31], they appear to be the least stably
expressed genes within the hepatic tissue of mouse systems. Sim-
ilarly, although Gapdh is a commonly used reference gene and was
stably expressed in rats treated with TCDD, it was only moderately
stable within the mouse models. Additionally, Gapdh mRNA abun-
dance increases 4-fold in response to TCDD in human keratinocytes
[24]. The individual reference genes which proved to be the most
stable were Hprt and Eef1a1; however, using certain combinations
of two or more genes was more stable than any individual gene
and the use of all seven candidate genes achieved the highest sta-
bility overall. Through this study, we found that the most signiﬁ-
cant factor surrounding reference gene selection is the number of
reference genes implemented. This work provides a template for
identifying reference genes for studying speciﬁc toxicological
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